{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:46:30Z","timestamp":1791225990541,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":410,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.coi.2012.03.014","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T21:39:08Z","timestamp":1336772348000},"page":"343-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":131,"title":["Vaccines against mucosal infections"],"prefix":"10.1016","volume":"24","author":[{"given":"Jan","family":"Holmgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Mari","family":"Svennerholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2012.03.014_bib0005","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0140-6736(10)60549-1","article-title":"Global, regional, and national causes of child mortality in 2008: a systematic analysis","volume":"375","author":"Black","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2012.03.014_bib0010","series-title":"New Generation Vaccines","first-page":"506","article-title":"Oral cholera vaccines","author":"Holmgren","year":"2010"},{"key":"10.1016\/j.coi.2012.03.014_bib0015","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1586\/erv.11.106","article-title":"Mucosal immunity to poliovirus","volume":"10","author":"Ogra","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.coi.2012.03.014_bib0020","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1365-3083.1977.tb00376.x","article-title":"Boosting of secretory IgA antibody responses in man by parenteral cholera vaccination","volume":"6","author":"Svennerholm","year":"1977","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.coi.2012.03.014_bib0025","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/infdis\/143.5.707","article-title":"Antibody responses to live and killed poliovirus vaccines in the milk of Pakistani and Swedish women","volume":"143","author":"Svennerholm","year":"1981","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2012.03.014_bib0030","first-page":"1","article-title":"Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues","volume":"354","author":"Czerkinsky","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.coi.2012.03.014_bib0035","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nature10392","article-title":"Evidence for several waves of global transmission in the seventh cholera pandemic","volume":"477","author":"Mutreja","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.coi.2012.03.014_bib0040","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/158.2.372","article-title":"Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial","volume":"158","author":"Clemens","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2012.03.014_bib0045","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/0140-6736(91)92590-X","article-title":"Prevention of travellers\u2019 diarrhoea by oral B-subunit\/whole-cell cholera vaccine","volume":"338","author":"Peltola","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2012.03.014_bib0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1708-8305.1995.tb00615.x","article-title":"Safety, immunogenicity, and protective efficacy of the Whole-Cell\/recombinant B Subunit (WC\/rBS) oral cholera vaccine against travelers\u2019 diarrhea","volume":"2","author":"Scerpella","year":"1995","journal-title":"J Travel Med"},{"key":"10.1016\/j.coi.2012.03.014_bib0055","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrgastro.2011.174","article-title":"New-generation vaccines against cholera","volume":"8","author":"Clemens","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.coi.2012.03.014_bib0060","doi-asserted-by":"crossref","first-page":"e1289","DOI":"10.1371\/journal.pntd.0001289","article-title":"Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial","volume":"5","author":"Sur","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coi.2012.03.014_bib0065","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S0950268809990550","article-title":"El Tor cholera with severe disease: a new threat to Asia and beyond","volume":"138","author":"Siddique","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.coi.2012.03.014_bib0070","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","article-title":"Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area","volume":"18","author":"Richie","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2012.03.014_bib0075","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(05)66550-6","article-title":"Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis","volume":"366","author":"Ali","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2012.03.014_bib0080","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1371\/journal.pmed.0040336","article-title":"Controlling endemic cholera with oral vaccines","volume":"4","author":"Longini","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.coi.2012.03.014_bib0085","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1016\/j.vaccine.2010.05.008","article-title":"Cholera vaccines: WHO position paper-Recommendations","volume":"28","author":"WHO Publication","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2012.03.014_bib0090","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.vaccine.2010.11.016","article-title":"Serological response and persistence in schoolchildren with high baseline seropositive rate after receiving 2009 pandemic influenza A(H1N1) vaccine","volume":"29","author":"Chao","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2012.03.014_bib0095","doi-asserted-by":"crossref","first-page":"8767","DOI":"10.1073\/pnas.1019712108","article-title":"Estimating the reproductive numbers for the 2008\u20132009 cholera outbreaks in Zimbabwe","volume":"108","author":"Mukandavire","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2012.03.014_bib0100","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.1371\/journal.pntd.0001006","article-title":"Use of oral cholera vaccines in an outbreak in Vietnam: a case control study","volume":"5","author":"Anh","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.coi.2012.03.014_bib0105","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.coi.2012.03.014_bib0110","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1016\/j.vaccine.2007.08.027","article-title":"Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials","volume":"25","author":"Fraser","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2012.03.014_bib0115","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0140-6736(98)09001-1","article-title":"Typhoid fever in children aged less than 5 years","volume":"354","author":"Sinha","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2012.03.014_bib0120","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3201\/eid1102.040422","article-title":"Bacteremic typhoid fever in children in an urban slum, Bangladesh","volume":"11","author":"Brooks","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.coi.2012.03.014_bib0125","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0264-410X(99)00231-5","article-title":"Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine","volume":"17","author":"Levine","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2012.03.014_bib0130","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/j.vaccine.2011.01.093","article-title":"Room temperature stabilization of oral, live attenuated Salmonella enterica serovar Typhi-vectored vaccines","volume":"29","author":"Ohtake","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2012.03.014_bib0135","first-page":"625","article-title":"Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China","volume":"79","author":"Yang","year":"2001","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.coi.2012.03.014_bib0140","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa0807521","article-title":"A cluster-randomized effectiveness trial of Vi typhoid vaccine in India","volume":"361","author":"Sur","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2012.03.014_bib0145","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1084\/jem.166.5.1510","article-title":"Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals","volume":"166","author":"Szu","year":"1987","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2012.03.014_bib0150","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1128\/IAI.72.11.6586-6588.2004","article-title":"Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children","volume":"72","author":"Canh","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.coi.2012.03.014_bib0155","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/CVI.00532-10","article-title":"The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines","volume":"18","author":"Thiem","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.coi.2012.03.014_bib0160","doi-asserted-by":"crossref","first-page":"e25398","DOI":"10.1371\/journal.pone.0025398","article-title":"Safety, immunogenicity and dose ranging of a new Vi-CRM conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults","volume":"6","author":"van Damme","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coi.2012.03.014_bib0165","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1473-3099(11)70253-5","article-title":"2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis","volume":"12","author":"Tate","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2012.03.014_bib0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1471-2458-7-281","article-title":"Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing countries","volume":"7","author":"Simpson","year":"2007","journal-title":"BMC Public Health"},{"key":"10.1016\/j.coi.2012.03.014_bib0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2012.03.014_bib0180","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.vaccine.2011.12.092","article-title":"Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic review","volume":"30","author":"Kawai","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2012.03.014_bib0185","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3201\/eid1202.050006","article-title":"Rotavirus and severe childhood diarrhea","volume":"12","author":"Parashar","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coi.2012.03.014_bib0190","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1016\/S0264-410X(01)00242-0","article-title":"Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants","volume":"19","author":"Clements-Mann","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2012.03.014_bib0195","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Intussusception among infants given an oral rotavirus vaccine","volume":"344","author":"Murphy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2012.03.014_bib0200","doi-asserted-by":"crossref","first-page":"e1002115","DOI":"10.1371\/journal.ppat.1002115","article-title":"Rotavirus stimulates release of serotonin (5-HT) from human enterochromaffin cells and activates brain structures involved in nausea and vomiting","volume":"7","author":"Hagbom","year":"2011","journal-title":"PLoS Pathog"},{"issue":"Suppl.","key":"10.1016\/j.coi.2012.03.014_bib0205","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1086\/653549","article-title":"Influence of potential protective mechanisms on the development of live rotavirus vaccines","volume":"202","author":"Ward","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2012.03.014_bib0210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJMoa1006261","article-title":"Protective effect of natural rotavirus infection in an Indian birth cohort","volume":"365","author":"Gladstone","year":"2011","journal-title":"N Engl J Med"},{"issue":"Suppl.","key":"10.1016\/j.coi.2012.03.014_bib0215","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1086\/653547","article-title":"Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa","volume":"202","author":"Pawinski","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2012.03.014_bib0220","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Armah","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2012.03.014_bib0225","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2012.03.014_bib0230","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1016\/j.vaccine.2010.06.006","article-title":"Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets","volume":"28","author":"Wang","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2012.03.014_bib0235","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0140-6736(11)61051-9","article-title":"Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis","volume":"378","author":"Nair","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2012.03.014_bib0240","series-title":"New Generation Vaccines","first-page":"532","article-title":"Influenza","author":"Treanor","year":"2010"},{"key":"10.1016\/j.coi.2012.03.014_bib0245","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/1040841X.2010.536523","article-title":"An overview of influenza A virus receptors","volume":"37","author":"Ge","year":"2011","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.coi.2012.03.014_bib0250","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live attenuated influenza vaccine (FluMist(R); Fluenz): a review of its use in the prevention of seasonal influenza in children and adults","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.coi.2012.03.014_bib0255","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.coi.2012.03.014_bib0260","doi-asserted-by":"crossref","first-page":"A40","DOI":"10.1016\/j.vaccine.2011.04.122","article-title":"Live attenuated pandemic influenza vaccine: clinical studies on A\/17\/California\/2009\/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries","volume":"29","author":"Rudenko","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2012.03.014_bib0265","first-page":"846","article-title":"Update on vaccine-derived polioviruses worldwide, July 2009\u20132011","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coi.2012.03.014_bib0270","doi-asserted-by":"crossref","first-page":"8205","DOI":"10.1016\/j.vaccine.2011.08.059","article-title":"Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission","volume":"29","author":"Okayasu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2012.03.014_bib0275","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/infdis\/jir721","article-title":"Randomized trial of type 1 and type 3 oral monovalent poliovirus vaccines in newborns in Africa","volume":"205","author":"Waggie","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2012.03.014_bib0280","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/INF.0b013e31823faa5f","article-title":"Immunologic response to oral polio vaccine in human immunodeficiency virus-infected and uninfected Zimbabwean children","volume":"31","author":"Gnanashanmugam","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.coi.2012.03.014_bib0285","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1016\/j.vaccine.2008.07.026","article-title":"World wide experience with inactivated poliovirus vaccine","volume":"26","author":"Bonnet","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2012.03.014_bib0290","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.vaccine.2003.07.016","article-title":"Herd immunity and herd protection","volume":"22","author":"Paul","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2012.03.014_bib0295","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/infdis\/jir723","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial","volume":"205","author":"Liao","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2012.03.014_bib0300","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1016\/j.ijid.2011.10.002","article-title":"Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines","volume":"16","author":"Cadorna-Carlos","year":"2012","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.coi.2012.03.014_bib0305","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0140-6736(09)60950-8","article-title":"Child undernutrition, tropical enteropathy, toilets, and handwashing","volume":"374","author":"Humphrey","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2012.03.014_bib0310","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature10213","article-title":"Human nutrition, the gut microbiome and the immune system","volume":"474","author":"Kau","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.coi.2012.03.014_bib0315","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000129624","article-title":"Determinants of responses to oral vaccines in developing countries","volume":"66","author":"Sack","year":"2008","journal-title":"Ann Nestle\u2019 (Engl)"},{"key":"10.1016\/j.coi.2012.03.014_bib0320","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/368132","article-title":"Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine","volume":"187","author":"Albert","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2012.03.014_bib0325","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.vaccine.2008.12.036","article-title":"Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding","volume":"27","author":"Ahmed","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2012.03.014_bib0330","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1086\/315837","article-title":"Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR","volume":"182","author":"Cooper","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2012.03.014_bib0335","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MOP.0b013e32834eb625","article-title":"An overview of cholera vaccines and their public health implications","volume":"24","author":"Desai","year":"2012","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.coi.2012.03.014_bib0340","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","article-title":"Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up","volume":"335","author":"Clemens","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2012.03.014_bib0345","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(94)90755-2","article-title":"Protective efficacy of oral whole-cell\/recombinant-B-subunit cholera vaccine in Peruvian military recruits","volume":"344","author":"Sanchez","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2012.03.014_bib0350","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa043323","article-title":"Effectiveness of mass oral cholera vaccination in Beira, Mozambique","volume":"352","author":"Lucas","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2012.03.014_bib0355","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(87)91316-X","article-title":"Protective activity of Vi capsular polysaccharide vaccine against typhoid fever","volume":"2","author":"Klugman","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2012.03.014_bib0360","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJM198710293171801","article-title":"Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report","volume":"317","author":"Acharya","year":"1987","journal-title":"New Engl J Med"},{"key":"10.1016\/j.coi.2012.03.014_bib0365","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"New Engl J Med"},{"key":"10.1016\/j.coi.2012.03.014_bib0370","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Zaman","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2012.03.014_bib0375","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1001\/jama.2009.756","article-title":"Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua","volume":"301","author":"Patel","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.coi.2012.03.014_bib0390","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(07)61744-9","article-title":"Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study","volume":"370","author":"Vesikari","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2012.03.014_bib0380","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMoa0904797","article-title":"Effect of human rotavirus vaccine on severe diarrhea in African infants","volume":"362","author":"Madhi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2012.03.014_bib0385","doi-asserted-by":"crossref","first-page":"c2825","DOI":"10.1136\/bmj.c2825","article-title":"Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study","volume":"340","author":"de Palma","year":"2010","journal-title":"BMJ"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791512000635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791512000635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:33:17Z","timestamp":1760603597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791512000635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0952791512000635"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2012.03.014","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccines against mucosal infections","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2012.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}